Cargando…
Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
BACKGROUND: The p23.2 region of human chromosome 8 is frequently deleted in several types of epithelial cancer and those deletions appear to be associated with poor prognosis. Cub and Sushi Multiple Domains 1 (CSMD1) was positionally cloned as a candidate for the 8p23 suppressor but point mutations...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1239921/ https://www.ncbi.nlm.nih.gov/pubmed/16153303 http://dx.doi.org/10.1186/1475-2867-5-29 |
_version_ | 1782125034503929856 |
---|---|
author | Richter, Toni M Tong, Benton D Scholnick, Steven B |
author_facet | Richter, Toni M Tong, Benton D Scholnick, Steven B |
author_sort | Richter, Toni M |
collection | PubMed |
description | BACKGROUND: The p23.2 region of human chromosome 8 is frequently deleted in several types of epithelial cancer and those deletions appear to be associated with poor prognosis. Cub and Sushi Multiple Domains 1 (CSMD1) was positionally cloned as a candidate for the 8p23 suppressor but point mutations in this gene are rare relative to the frequency of allelic loss. In an effort to identify alternative mechanisms of inactivation, we have characterized CSMD1 expression and epigenetic modifications in head and neck squamous cell carcinoma cell lines. RESULTS: Only one of the 20 cell lines examined appears to express a structurally normal CSMD1 transcript. The rest express transcripts which either lack internal exons, terminate abnormally or initiate at cryptic promoters. None of these truncated transcripts is predicted to encode a functional CSMD1 protein. Cell lines that express little or no CSMD1 RNA exhibit DNA methylation of a specific region of the CpG island surrounding CSMD1's first exon. CONCLUSION: Correlating methylation patterns and expression suggests that it is modification of the genomic DNA preceding the first exon that is associated with gene silencing and that methylation of CpG dinucleotides further 3' does not contribute to inactivation of the gene. Taken together, the cell line data suggest that epigenetic silencing and aberrant splicing rather than point mutations may be contributing to the reduction in CSMD1 expression in squamous cancers. These mechanisms can now serve as a focus for further analysis of primary squamous cancers. |
format | Text |
id | pubmed-1239921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-12399212005-10-04 Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines Richter, Toni M Tong, Benton D Scholnick, Steven B Cancer Cell Int Primary Research BACKGROUND: The p23.2 region of human chromosome 8 is frequently deleted in several types of epithelial cancer and those deletions appear to be associated with poor prognosis. Cub and Sushi Multiple Domains 1 (CSMD1) was positionally cloned as a candidate for the 8p23 suppressor but point mutations in this gene are rare relative to the frequency of allelic loss. In an effort to identify alternative mechanisms of inactivation, we have characterized CSMD1 expression and epigenetic modifications in head and neck squamous cell carcinoma cell lines. RESULTS: Only one of the 20 cell lines examined appears to express a structurally normal CSMD1 transcript. The rest express transcripts which either lack internal exons, terminate abnormally or initiate at cryptic promoters. None of these truncated transcripts is predicted to encode a functional CSMD1 protein. Cell lines that express little or no CSMD1 RNA exhibit DNA methylation of a specific region of the CpG island surrounding CSMD1's first exon. CONCLUSION: Correlating methylation patterns and expression suggests that it is modification of the genomic DNA preceding the first exon that is associated with gene silencing and that methylation of CpG dinucleotides further 3' does not contribute to inactivation of the gene. Taken together, the cell line data suggest that epigenetic silencing and aberrant splicing rather than point mutations may be contributing to the reduction in CSMD1 expression in squamous cancers. These mechanisms can now serve as a focus for further analysis of primary squamous cancers. BioMed Central 2005-09-09 /pmc/articles/PMC1239921/ /pubmed/16153303 http://dx.doi.org/10.1186/1475-2867-5-29 Text en Copyright © 2005 Richter et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Primary Research Richter, Toni M Tong, Benton D Scholnick, Steven B Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines |
title | Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines |
title_full | Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines |
title_fullStr | Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines |
title_full_unstemmed | Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines |
title_short | Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines |
title_sort | epigenetic inactivation and aberrant transcription of csmd1 in squamous cell carcinoma cell lines |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1239921/ https://www.ncbi.nlm.nih.gov/pubmed/16153303 http://dx.doi.org/10.1186/1475-2867-5-29 |
work_keys_str_mv | AT richtertonim epigeneticinactivationandaberranttranscriptionofcsmd1insquamouscellcarcinomacelllines AT tongbentond epigeneticinactivationandaberranttranscriptionofcsmd1insquamouscellcarcinomacelllines AT scholnickstevenb epigeneticinactivationandaberranttranscriptionofcsmd1insquamouscellcarcinomacelllines |